US9181187, Compound E

ID: ALA3926646

Chembl Id: CHEMBL3926646

PubChem CID: 10229275

Max Phase: Preclinical

Molecular Formula: C28H31NO6S

Molecular Weight: 509.62

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N(CC(C)C)c2cc3c(cc2OCc2ccc(/C=C/C(=O)O)cc2)CCC3)o1

Standard InChI:  InChI=1S/C28H31NO6S/c1-19(2)17-29(36(32,33)28-14-7-20(3)35-28)25-15-23-5-4-6-24(23)16-26(25)34-18-22-10-8-21(9-11-22)12-13-27(30)31/h7-16,19H,4-6,17-18H2,1-3H3,(H,30,31)/b13-12+

Standard InChI Key:  PMSJJQQHDLYFCS-OUKQBFOZSA-N

Associated Targets(non-human)

Ptger1 Prostanoid EP1 receptor (301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 509.62Molecular Weight (Monoisotopic): 509.1872AlogP: 5.60#Rotatable Bonds: 10
Polar Surface Area: 97.05Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.85CX Basic pKa: CX LogP: 6.10CX LogD: 2.86
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: -0.59

References

1.  (2015)  Therapeutic agent for urinary excretion disorder, 

Source

Source(1):